ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 620

Innate Immune Stimulation Triggers Altered IL-1a/b Gene Expression and Experimental Spondyloarthritis in HLA-B27/huβ2m Transgenic Rats

Melissa N. van Tok1,2, Leonie M. van Duivenvoorde3, Nimman Satumtira4, Martha L. Dorris4, Joel D. Taurog4 and Dominique L. Baeten1, 1Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 2Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 3Experimental Immunology, Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 4Internal Medicine, Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: animal models and spondylarthritis, IL-1

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Spondyloarthritis (SpA) does not display typical features of autoimmune diseases such as female predominance, presence of autoantibodies, or clinical response to T- and/or B cell targeting biologicals. Despite the strong association with MHC class I, CD8 T cells are not required for disease induction in the HLA-B27/huβ2m transgenic rat model. Moreover, the capability of HLA-B27 to misfold and thereby induce endoplasmatic reticulum stress and the direct recognition of HLA-B27 homodimers by NK cells suggest pathogenic mechanisms which may be independent of classical acquired immune responses. Therefore, we and others propose that SpA may be primarily driven by an innate immune response. Using the HLA-B27/huβ2m transgenic rat model,¹ we investigated this hypothesis by studying the effect of innate immune stimulation on ex vivo cytokine expression and in vivo development of arthritis and spondylitis. 

Methods: Splenocytes and bone marrow cells isolated from HLA-B27/huβ2m tg rats and controls were stimulated for 6 hours with 50 ng/ml LPS, 5 µg/ml zymosan or 5 µg/ml heat-inactivated Mycobacterium tuberculosis. TNF, IL-1, IL-6, IL-10 and IL-23p19 expression was measured by qPCR. In vivo, six week old male and female HLA-B27/huβ2m tg were immunized with a low dose of M. tuberculosisin incomplete Freund’s adjuvant. Rats were followed up for 60 days and scored clinically for arthritis and spondylitis. At day 60 hind limbs and tails were analysed for inflammation, destruction and new bone formation by histology. 

Results: In vitro stimulation of splenocytes with zymosan and with M. tuberculosis, but not with LPS, strongly induced gene expression of pro-inflammatory cytokines such as TNF, IL-1a, IL-1b and IL-6 in all 3 groups of rats. IL-1a and IL-1b, but not TNF or IL-6, were increased in the HLA-B27/huβ2m transgenic cells as compared to both HLA-B7/huβ2m tg and wild-type controls upon ex vivo stimulation. IL-10 and IL23p19 expression could not be detected in any of the groups after stimulation. In vivo, non-immunized HLA-B27/huβ2m tg males spontaneously develop arthritis and spondylitis after 4-6 months of age with an incidence of 70% and 40%, respectively, whereas female rats do not develop disease. Immunization of male HLA-B27/huβ2m tg rats with 30 µg of M. tuberculosis was sufficient to induce arthritis and spondylitis within 2-3 weeks with an incidence of 80-100%. Moreover, HLA-B27/huβ2m tg females developed similar disease when immunized with 60 µg of M. tuberculosis. Control rats were less sensitive to low doses of M. tuberculosis. Histologically in both male and female HLA-B27/huβ2m tg rats inflammation, destruction and new bone formation was detected in both peripheral and axial joints.

Conclusion:  The transgenic expression of HLA-B27/Hub2m increases the sensitivity to innate immune stimulation as evidenced by increased IL-1a and IL-1b expression ex vivo and development of arthritis and spondylitis in vivo. These data suggest that the B27/Hub2m expression lowers the threshold for innate immune activation of the IL-1 pathway, and this alone may be sufficient to trigger experimental SpA.  

References: 1. Tran TM et. al. Arthritis Rheum 2006; 54(4):1317-27


Disclosure:

M. N. van Tok,
None;

L. M. van Duivenvoorde,
None;

N. Satumtira,
None;

M. L. Dorris,
None;

J. D. Taurog,
None;

D. L. Baeten,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/innate-immune-stimulation-triggers-altered-il-1ab-gene-expression-and-experimental-spondyloarthritis-in-hla-b27hu%ce%b22m-transgenic-rats/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology